Drugs / BCG
last change Sep 2024 re-read 3 minutes ago

BCG

Developed for
urinary bladder carcinoma
Investigated by
Apices Soluciones S.L. · Fundacion Oncosur

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04134000 Feb 2020 → Jun 2024 urinary bladder carcinoma Fundacion Oncosur Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BCG ClinicalTrials.gov intervention name — accepted as the source's own label NCT04134000 ↗